Prenetics Global Ownership

PRE Stock  USD 4.43  0.07  1.56%   
The market capitalization of Prenetics Global is $54.12 Million. Prenetics Global has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.
 
Shares in Circulation  
First Issued
2006-03-31
Previous Quarter
12.2 M
Current Value
12.2 M
Avarage Shares Outstanding
49.4 M
Quarterly Volatility
28.8 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Some institutional investors establish a significant position in stocks such as Prenetics Global in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Prenetics Global, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
The current year's Dividend Paid And Capex Coverage Ratio is expected to grow to -14.34. As of November 28, 2024, Common Stock Shares Outstanding is expected to decline to about 10.7 M. The current year's Net Loss is expected to grow to about (162.8 M).
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prenetics Global. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For information on how to trade Prenetics Stock refer to our How to Trade Prenetics Stock guide.

Prenetics Stock Ownership Analysis

About 21.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.3. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Prenetics Global has Price/Earnings (P/E) ratio of 144.87. The entity recorded a loss per share of 3.73. The firm last dividend was issued on the February 17, 2016. Prenetics Global had 1:15 split on the 14th of November 2023. Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong. Prenetics Global is traded on NASDAQ Exchange in the United States. To find out more about Prenetics Global contact the company at 852 2210 9588 or learn more at https://www.prenetics.com.
Besides selling stocks to institutional investors, Prenetics Global also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Prenetics Global's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Prenetics Global's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Prenetics Global Quarterly Liabilities And Stockholders Equity

233.31 Million

About 21.0% of Prenetics Global are currently held by insiders. Unlike Prenetics Global's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Prenetics Global's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Prenetics Global's insider trades

Prenetics Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Prenetics Global is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Prenetics Global backward and forwards among themselves. Prenetics Global's institutional investor refers to the entity that pools money to purchase Prenetics Global's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Prudential Corp Plc2024-06-30
483 K
Aspex Management (hk) Ltd2024-06-30
346.1 K
Nomura Holdings Inc2024-06-30
323 K
Ubs Group Ag2024-06-30
40.1 K
Aspire Private Capital, Llc2024-09-30
114
Bank Of America Corp2024-06-30
111
Wolverine Asset Management Llc2024-09-30
1.0
Yu Fan2024-06-30
0.0
Advisor Group Holdings, Inc.2024-06-30
0.0
Note, although Prenetics Global's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Prenetics Global Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Prenetics Global insiders, such as employees or executives, is commonly permitted as long as it does not rely on Prenetics Global's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Prenetics Global insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Prenetics Global Outstanding Bonds

Prenetics Global issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Prenetics Global uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Prenetics bonds can be classified according to their maturity, which is the date when Prenetics Global has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Prenetics Global Corporate Filings

6K
27th of November 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
13A
14th of November 2024
An amended filing to the original Schedule 13G
ViewVerify
7th of November 2024
Other Reports
ViewVerify
1st of May 2024
Other Reports
ViewVerify

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Prenetics Global is a strong investment it is important to analyze Prenetics Global's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Prenetics Global's future performance. For an informed investment choice regarding Prenetics Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prenetics Global. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For information on how to trade Prenetics Stock refer to our How to Trade Prenetics Stock guide.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Reinsurance space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Prenetics Global. If investors know Prenetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Prenetics Global listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.73)
Revenue Per Share
1.878
Quarterly Revenue Growth
0.043
Return On Assets
(0.10)
Return On Equity
(0.22)
The market value of Prenetics Global is measured differently than its book value, which is the value of Prenetics that is recorded on the company's balance sheet. Investors also form their own opinion of Prenetics Global's value that differs from its market value or its book value, called intrinsic value, which is Prenetics Global's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Prenetics Global's market value can be influenced by many factors that don't directly affect Prenetics Global's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Prenetics Global's value and its price as these two are different measures arrived at by different means. Investors typically determine if Prenetics Global is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Prenetics Global's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.